Acupuncture plus sedative may shield stroke survivors from depression

NCT ID NCT07739329

Not yet recruiting Prevention Sponsor: Min Su Source: ClinicalTrials.gov ↗

First seen Jul 31, 2026 · Last updated Jul 31, 2026

Summary

This trial tests whether combining electroacupuncture with a sedative drug called dexmedetomidine can prevent depression in people who recently had an ischemic stroke. Participants at high risk for post-stroke depression will receive either the combined treatment, a sham version, or a placebo. The goal is to see if this integrative approach can reduce the chance of developing depression within three months after the stroke.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Electroacupuncture combined with intranasal dexmedetomidine
What this could lead to: If effective, this combined therapy could offer a safe way to prevent depression in people who have recently had a stroke, improving their recovery and quality of life.
What could go wrong: This is a single trial, and results may not apply to all stroke survivors. The treatments carry risks, such as bleeding or infection from needles, and sedation or low blood pressure from dexmedetomidine.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ISCHEMIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ischemic stroke

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

POST-STROKE DEPRESSION

More trials for these conditions

Other studies related to the condition(s) this trial covers.